Marcela Guevara

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.

X. Beristain, J. Castilla, A. Barricarte, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.

E. Hak, S. Costanzo, F. Galtier, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.

J. Castilla, A. Barricarte, M. Guevara, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Heptavalent-pneumococcal conjugate vaccine (Prevenar). Differences in effectiveness between populations].

J. Castilla, A. Barricarte, M. Guevara, 2008, Anales del sistema sanitario de Navarra.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

M. Valenciano, G. Fagherazzi, F. Galtier, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Brain and Central Nervous System Cancer Incidence in Navarre (Spain), 1973-2008 and Projections for 2014

E. Ardanaz, M. Guevara, C. Moreno-Iribas, 2015, Journal of Cancer.

Compositional analysis of dietary patterns

V. Moreno, M. Kogevinas, G. Coenders, 2018, Statistical methods in medical research.